Difference in Rill Costs With INA-CBGs Rates and Treatment Rationality of Inpatient Asthma Children
DOI:
https://doi.org/10.25026/jtpc.v8i2.619Keywords:
asthma, real costs, INA-CBGs, drug-related problemsAbstract
Asthma in children may affect children's efficiency at school because frequent attacks occur which disrupt children's activities, so that asthma in children is a serious problem that requires appropriate treatment. The aim was to know the difference in real costs and INA-CBGs rates and to analyze Drug-Related Problems (DRP) based on the severity of asthma and the real costs for childhood asthma at Anwar Medika Sidoarjo Hospital. The design of this study was retrospective using patient medical record data collection, for January 2020-December 2022. Data collection containing real cost data and BPJS claim cost data. Analysis of DRP based on PCNE (Pharmaceutical Care Network Europe) includes problems and causes. There were 77 subjects. the real costs for the severity of mild asthma class I, class III, and moderate asthma class II were high when compared with the INA-CBGS rates, while the severity level of severe asthma class III it was found that the real costs were lower than the INA-CBGS rates. There is no difference between total real costs and INA-CBGS rates for asthma cases in BPJS participating children. The average real cost is Rp. 2,557,453 and the average INA-CBGs tariff is Rp. 2,792,873. There was no significant difference between real costs and INA-CBGS rates (P=0.162). All respondents experienced DRP (100%) and the highest incidence of DRP was M3.1 and P1.2 in 44 people (57.14%) with 180 cases (60.82%). In 77 patients with a total number of cases of 296, the real costs were mostly incurred in class III mild asthma patients (58 people), namely DRP type M3.1 with P1.2 with an average cost of Rp. 2,640,221.
Downloads
References
[1] Global Initiative for Asthma. 2023. Global Strategy for Asthma Management and Prevention. 2018. Available from: https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-tracked_v1.3.pdf.
[2] Bush A. Pathophysiological Mechanisms of Asthma. Front Pediatr. 2019;7:68. doi: 10.3389/fped.2019.00068.
[3] Zahran HS, Bailey CM, Damon SA, Garbe PL, Breysse PN. Vital Signs?: Asthma in Children — United States, 2001–2016. Morbidity and Mortality Weekly Report (MMWR). 2018;67(5):149–55. https://doi.org/10.15585/mmwr.mm6705e1.
[4] Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Frontiers in Pediatrics. 2019;7:1–15. https://doi.org/10.3389/fped.2019.00246.
[5] Serebrisky D, Wiznia A. Pediatric asthma: A global epidemic. Annals of Global Health. 2019;85(1):1–6. https://doi.org/10.5334/aogh.2416.
[6] Kresnayasa MM, Hartawan BNI, Sidiartha LGI, Wati KD. Karakteristik Asma Pada Anak Di Puskesman I Denpasar Timur Tahun 2019-2021. Jurnal Medika Udayana. 2021;10(8):13–8.
[7] Pusdatin Kemenkes RI. (2019). Infodatin Asma. Journal of Chemical Information and Modeling, 01(01), 1689–1699. https://pusdatin.kemkes.go.id/resources//download/pusdatin/infodatin/infodatin-asma-cetak.pdf.
[8] Suprapto ARA. Upaya Preventif Terhadap Serangan Asma Camellia Sinensis Leaf Extract As a Potent Preventive Measure of Asthma Attack. Jurnal Ilmiah Mahasiswa Kedokteran Indonesia. 2021;9:110–6.
[9] Castillo JR, Peters SP, Busse WW. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment. J Allergy Clin Immunol Pract. 2017;5(4):918-27. doi: 10.1016/j.jaip.2017.05.001.
[10] Fergeson JE, Patel SS, Lockey RF. Acute asthma, prognosis, and treatment. J Allergy Clin Immunol. 2017;139(2):438-47. doi: 10.1016/j.jaci.2016.06.054.
[11] Litanto A, Kartini K. Kekambuhan asma pada perempuan dan berbagai faktor yang memengaruhinya. Jurnal Biomedika Dan Kesehatan. 2020;4(2):79–86. https://doi.org/10.18051/jbiomedkes.2021.v4.79-86.
[12] Cottrill KA, Chandler JD, Kobara S, Stephenson ST, Mohammad AF, Tidwell M, Mason C, Dresser MV, Patrignani J, Kamaleswaran R, Fitzpatrick AM. Metabolomics identifies disturbances in arginine , phenylalanine , and glycine metabolism as differentiating features of exacerbating atopic asthma in children. Journal of Allergy and Clinical Immunology Global. 2023;2(3):100115. https://doi.org/10.1016/j.jacig.2023.100115.
[13] Trivedi M, Denton E. Asthma in children and adults—what are the differences and what can they tell us about asthma?. Frontiers in Pediatrics. 2019;7:1–15. https://doi.org/10.3389/fped.2019.00256.
[14] Putri PP, Nisa K, Wahyudo R. Program Olahraga Renang?: Intervensi Non-Farmakologis yang Efektif pada Asma Anak Swimming Training Programme?: An Effective Non-Pharmacological Intervention for Pediatric Asthma. Medula. 2021;7(5):37–41.
[15] Lorensia A, Fatmala D. Analisis masalah terkait obat pada pengobatan asma rawat jalan. Jurnal Ilmiah Manuntung. 2021;7(1):126–37. http://repository.ubaya.ac.id/id/eprint/39631.
[16] Kementerian Kesehatan RI. (2021). Permenkes Nomor 7 Tahun 2021 tentang Pelayanan Kesehatan pada Jaminan Kesehatan Nasional.
[17] Ananta I. Penerapan pola pembayaran INA-CBGs BPJS kesehatan dalam tinjauan regulasi dan implementasi. Prosiding Semnas Tatantangan Pengembangan Ilmu Akuntansi. 2016;275–290.
[18] Monica RD, Mawar F, Suryati Y, Pujilestari I, Rohmayani D, Hendrati A. Analisis Perbedaan Tarif Riil Rumah Sakit dengan Tarif INA-CBG’s Berdasarkan Kelengkapan Medis Pasien Rawat Inap Pada Kasus Persalinan Sectio Caesarea Guna Pengendalian Biaya Rumah Sakit TNI AU Dr. M. Salamun Bandung. Jmiki. 2021;99(1):90–6. https://jmiki.aptirmik.or.id/index.php/jmiki/article/view/90.
[19] Nisa BI. Faktor-faktor yang Mempengaruhi Biaya antara Biaya Riil dan Tarif INA CBGs pada Pasien Jantung Koroner Rawat Inap JKN di RSUD Tugurejo Semarang Tahun 2019. Fakultas Ilmu Kesehatan Masyarakat. Universitas Negeri Semarang. 2020;184.
[20] Agustina PB, Muchlis N. Analisis Biaya Rill dan Tarif INA CBG’s Di Rumah Sakit Umum Bahagia Kota Makassar. Journal of Muslim Community Health (JMCH),. 2020;1(2):13–25.
[21] Pratama AM, Lorensia A. Profil Biaya Pengobatan Serangan Asma berdasarkan Kelas Rawat Inap. Surya Medika. 2021;16(2):13-8.
[22] Papi A, Blasi F, Canonica GW, Morandi L, Richeldi L, Rossi A. Treatment strategies for asthma: reshaping the concept of asthma management. Allergy Asthma Clin Immunol. 2020;16:75. doi: 10.1186/s13223-020-00472-8.
[23] Pharmaceutical Care Network Europe Association. PCNE Classification for Drug-Related Problems V9.1 - Page 1: Classification for Drug related problems; 2020. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf.
[24] Lorensia A, Fatmala D. Analisis Masalah Terkait Obat Pada Pengobatan. Jurnal Ilmiah Manuntung. 2021;7(1):126–37.
[25] Lorensia A, Wijaya RI. Hubungan Jumlah Obat yang Digunakan Terhadap Risiko Terjadinya Drug-Related Problems pada Pasien Asma di Suatu Rumah Sakit di Surabaya. Jurnal of Tropical Pharmacy and Chemistry. 2016;3(3):232-8.
[26] Kemenkes RI. (2016). Indonesian Case Based Groups (INA-CBG’s) dan non Indonesian Case Based. Peraturan Menteri Kesehatan Republik Indonesia Nomor 52 Tahun 2016 Tentang Standar Tarif Pelayanan Kesehatan Dalam Penyelenggaraan Program Jaminan Kesehatan.
[27] Singh JA, Siddiqi M, Parameshwar P, Chandra-Mouli V. World Health Organization Guidance on Ethical Considerations in Planning and Reviewing Research Studies on Sexual and Reproductive Health in Adolescents. J Adolesc Health. 2019;64(4):427-9. doi: 10.1016/j.jadohealth.2019.01.008.
[28] Hinrichs-Krapels S, Ditewig B, Boulding H, Chalkidou A, Erskine J, Shokraneh F. Purchasing high-cost medical devices and equipment in hospitals: a systematic review. BMJ Open. 2022;12(9):e057516. doi: 10.1136/bmjopen-2021-057516.
[29] Permenkes No. 3. (2023). Peraturan Menteri Kesehatan Republik Indonesia No. 3 Tahun 2023 Tentang Standar Tarif Pelayanan Kesehatan Dalam Penyelenggaraan Program Jaminan Kesehatan. Menteri Kesehatan RI, 1–721. https://www.kemkes.go.id/downloads/resources/download/lain/PERMENKES-NO-3-TAHUN-2023-TTG-STANDAR-TARIF-PELAYANAN-KESEHATAN-DALAM-PENYELENGGARAAN-JAMINAN-KESEHATAN-1.pdf.
[30] Marques L, Vale N. Salbutamol in the Management of Asthma: A Review. Int J Mol Sci. 2022;23(22):14207. doi: 10.3390/ijms232214207.
[31] Tchana B, Caffarelli C. Inhaled Short-Acting Beta Agonist Treatment-Associated Supraventricular Tachycardia in Children: Still a Matter of Concern in Pediatric Emergency Departments? Children (Basel). 2023;10(4):699. doi: 10.3390/children10040699.
[32] Patel R, Naqvi SA, Griffiths C, Bloom CI. Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review. BMJ Open Respir Res. 2020;7(1):e000756. doi: 10.1136/bmjresp-2020-000756.
[33] Normansell R, Sayer B, Waterson S, Dennett EJ, Del Forno M, Dunleavy A. Antibiotics for exacerbations of asthma. Cochrane Database Syst Rev. 2018;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2.
[34] Stefan MS, Shieh MS, Spitzer KA, Pekow PS, Krishnan JA, Au DH, Lindenauer PK. Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids. JAMA Intern Med. 2019;179(3):333-9. doi: 10.1001/jamainternmed.2018.5394.
[35] Fisher JD, Sakaria RP, Siddiqui KN, Ivey KJ, Bali L, Burnette K. Initial ED oxygen saturation ?90% increases the risk of a complicated hospital course in pediatric asthmatics requiring admission. Am J Emerg Med. 2019;37(9):1743-45. doi: 10.1016/j.ajem.2019.06.020.
[36] Nagakura A, Morikawa Y, Takasugi N, Funakoshi H, Miura Y, Ota T, Shimizu A, Shimizu K, Shirane S, Hataya H. Oxygen saturation targets in pediatric respiratory disease. Pediatr Int. 2022;64(1):e15129. doi: 10.1111/ped.15129.
[37] Heckroth M, Luckett RT, Moser C, Parajuli D, Abell TL. Nausea and Vomiting in 2021: A Comprehensive Update. J Clin Gastroenterol. 2021;55(4):279-99. doi: 10.1097/MCG.0000000000001485.
[38] Lorensia A, Ikawati Z, Andayani TM, Suryadinata RV, Hantoro AA, Firanita LD. Efektivitas dan Risiko Toksisitas Aminofilin Intravena pada Pengobatan Awal Serangan Asma. Indonesian Journal of Clinical Pharmacy. 2018;7(2):78-88.
[39] Mahdayana ID, Sudjatmiko S, Sumarno S, Padolo E. Studi Penggunaan Profilaksis Stress Ulcer pada Pasien Bedah Digestif di RSUD dr.Soetomo Surabaya. Pharmaceutical Journal of Indonesia. 2020;005(02):73–78. https://doi.org/10.21776/ub.pji.2020.005.02.1.
[40] Fu LS, Lin CC, Wei CY, Lin CH, Huang YC. Risk of acute exacerbation between acetaminophen and ibuprofen in children with asthma. PeerJ. 2019;7:e6760. doi: 10.7717/peerj.6760.
[41] Sholihah SH. Efektivitas Pemberian Parasetamol Oral Versus Parasetamol Rektal Untuk Antipiretik Pada Anak: Systematic Review. Jurnal Ilmu Farmasi Dan Farmasi Klinik. 2020;17(01):22. https://doi.org/10.31942/jiffk.v17i01.3503.
[42] Pratiwi DAB, Anggraini N, Aeni N, Tinggi S, Kesehatan I, Global S. Kajian DRPs dan pola peresepan pada pasien rawat inap anak dengan asma. Stikes Surya Global. 2022;6(1):28–34.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Tropical Pharmacy and Chemistry

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.